Jeffrey Dayno, MD, chief medical officer of Harmony Biosciences, as well as John C. Jacobs, the chairman and CEO, shared their insight into the potential impact pitolisant can make in the treatment of narcolepsy and excessive daytime sleepiness.
from Front page feed https://ift.tt/2ZlqgfV
from Front page feed https://ift.tt/2ZlqgfV
Comments
Post a Comment